Spry Health Announces FDA Clearance of Groundbreaking Loop System, Designed to Transform Care for People with COPD


PALO ALTO, Calif.–(BUSINESS WIRE)–Spry Health, a leader in health management technologies and remote patient monitoring, today announced U.S. Food and Drug Administration (FDA) clearance to market the company’s Loop System. Loop is the first clinical-grade wearable that measures pulse oximetry, respiration rate and heart rate. With this FDA clearance, clinicians will now have a tool to remotely monitor their patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD), http://www.businesswire.com/news/home/20190408005227/en/Spry-Health-Announces-FDA-Clearance-Groundbreaking-Loop/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J